Hui Zhang is responsible for providing professional product solution & consulting service to ensure that Clarivate Analytics (formerly the IP & Science business of Thomson Reuters) meets the business growth and intelligence needs of Chinese customers. She is expert in product strategy for the widely used Newport® generics business development and API sourcing products and is involved in supporting all manner of exciting consulting projects for customers in many diverse fields in the generics and API business. With more than 15 years of R&D professional experience in pharmaceutical industry, much of it as a management consultant in China, EU & US, she has held position in Clarivate Analytics and ChiaTai TianQing Pharma. She worked as a Senior Manager in Strategic Marketing Dept. for her expertise lies in regulation and policy, therapeutic areas and indication selection, project screening, portfolio management and strategic market analysis. Hui holds a Master of International Pharmaceutical Engineering Management from Peking University.